Programmed autologous cleavage of platelet receptors

被引:37
作者
Berndt, M. C.
Karunakaran, D.
Gardiner, E. E.
Andrews, R. K.
机构
[1] Monash Univ, Dept Immunol, Alfred Med Res & Educ Precinct AMREP, Melbourne, Vic, Australia
[2] Monash Univ, Dept Biochem & Mol Biol, Alfred Med Res & Educ Precinct AMREP, Melbourne, Vic, Australia
关键词
GPIb-IX-V; GPVI; metalloproteineses; platelets; thrombosis;
D O I
10.1111/j.1538-7836.2007.02484.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet adhesion receptors play a critical role in vascular pathophysiology, and control platelet adhesion, activation and aggregation in hemostasis, thrombotic disease and atherogenesis. One of the key emerging mechanisms for regulating platelet function is the programmed autologous cleavage of platelet receptors. Induced by ligand binding or platelet activation, proteolysis at extracellular (ectodomain shedding) or intracellular (cytoplasmic domain deactivation) sites down-regulates the adheso-signaling function of receptors, thereby controlling not only platelet responsiveness, but in the case of ectodomain shedding, liberating soluble ectodomain fragments into plasma where they constitute potential modulators or markers. This review discusses the underlying mechanisms for dual proteolytic pathways of receptor regulation, and the impact of these pathways on thrombus formation and stability in vivo.
引用
收藏
页码:212 / 219
页数:8
相关论文
共 99 条
[1]   Thrombin interaction with platelet membrane glycoprotein Ibα [J].
Adam, F ;
Bouton, MC ;
Huisse, MG ;
Jandrot-Perrus, M .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (11) :461-464
[2]   Aspirin induces platelet receptor shedding via ADAM17 (TACE) [J].
Aktas, B ;
Pozgajova, M ;
Bergmeier, W ;
Sunnarborg, S ;
Offermanns, S ;
Lee, D ;
Wagner, DD ;
Nieswandt, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (48) :39716-39722
[3]   Shedding of growth hormone-binding protein is inhibited by hydroxamic acid-based protease inhibitors: proposed mechanism of activation of growth hormone-binding protein secretase [J].
Amit, T ;
Hochberg, Z ;
Yogev-Falach, M ;
Youdim, MBH ;
Barkey, RJ .
JOURNAL OF ENDOCRINOLOGY, 2001, 169 (02) :397-407
[4]   Platelet-derived CD40L -: The switch-hitting player of cardiovascular disease [J].
André, P ;
Nannizzi-Alaimo, L ;
Prasad, SK ;
Phillips, DR .
CIRCULATION, 2002, 106 (08) :896-899
[5]   CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism [J].
André, P ;
Prasad, KSS ;
Denis, CV ;
He, M ;
Papalia, JM ;
Hynes, RO ;
Phillips, DR ;
Wagner, DD .
NATURE MEDICINE, 2002, 8 (03) :247-252
[6]   Glycoprotein Ib-IX-V [J].
Andrews, RK ;
Gardiner, EE ;
Shen, Y ;
Whisstock, JC ;
Berndt, MC .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (08) :1170-1174
[7]   Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI [J].
Andrews, RK ;
Suzuki-Inoue, K ;
Shen, Y ;
Tulasne, D ;
Watson, SP ;
Berndt, MC .
BLOOD, 2002, 99 (11) :4219-4221
[8]   A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI [J].
Andrews, RK ;
Gardiner, EE ;
Asazuma, N ;
Berlanga, O ;
Tulasne, D ;
Nieswandt, B ;
Smith, AI ;
Berndt, MC ;
Watson, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :28092-28097
[9]   Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex [J].
Andrews, RK ;
Munday, AD ;
Mitchell, CA ;
Berndt, MC .
BLOOD, 2001, 98 (03) :681-687
[10]  
ANDREWS RK, 2006, PLATELETS, P2